Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 1
2008 1
2009 3
2010 2
2013 1
2014 4
2015 2
2016 3
2017 1
2018 1
2020 2
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and Treatment of Myopic Maculopathy.
Yokoi T, Ohno-Matsui K. Yokoi T, et al. Asia Pac J Ophthalmol (Phila). 2018 Nov-Dec;7(6):415-421. doi: 10.22608/APO.2018290. Epub 2018 Sep 26. Asia Pac J Ophthalmol (Phila). 2018. PMID: 30255668 Free article. Review.
Regarding visual impairment caused by advanced myopic chorioretinal atrophy, the only way to prevent blindness is to prevent myopia from developing or progressing at a young age before the axial length elongates extremely. As peripapillary diffuse atrophy in …
Regarding visual impairment caused by advanced myopic chorioretinal atrophy, the only way to prevent blindness is to prevent m …
Full-field Scotopic Threshold Improvement after Voretigene Neparvovec-rzyl Treatment Correlates with Chorioretinal Atrophy.
Stingl K, Stingl K, Schwartz H, Reid MW, Kempf M, Dimopoulos S, Kortuem F, Borchert MS, Lee TC, Nagiel A. Stingl K, et al. Ophthalmology. 2023 Jul;130(7):764-770. doi: 10.1016/j.ophtha.2023.02.015. Epub 2023 Feb 21. Ophthalmology. 2023. PMID: 36822437
PURPOSE: To analyze demographic and ophthalmic data in patients with and without chorioretinal atrophy after voretigene neparvovec-rzyl (VN) to identify possible causes for this phenomenon. ...CONCLUSIONS: The degree of FST improvement after VN appears to be strongl …
PURPOSE: To analyze demographic and ophthalmic data in patients with and without chorioretinal atrophy after voretigene neparv …
Myopic choroidal neovascularisation: current concepts and update on clinical management.
Wong TY, Ohno-Matsui K, Leveziel N, Holz FG, Lai TY, Yu HG, Lanzetta P, Chen Y, Tufail A. Wong TY, et al. Br J Ophthalmol. 2015 Mar;99(3):289-96. doi: 10.1136/bjophthalmol-2014-305131. Epub 2014 Jul 1. Br J Ophthalmol. 2015. PMID: 24990871 Free PMC article. Review.
Several treatments are available to ophthalmologists, but with the advent of new therapies there is a need for further consensus and clinical management recommendations. Verteporfin photodynamic therapy has been an established treatment for subfoveal myopic CNV for …
Several treatments are available to ophthalmologists, but with the advent of new therapies there is a need for further consensus and …
Genotype Phenotype Correlation and Variability in Microcephaly Associated With Chorioretinopathy or Familial Exudative Vitreoretinopathy.
Shurygina MF, Simonett JM, Parker MA, Mitchell A, Grigorian F, Lifton J, Nagiel A, Shpak AA, Dadali EL, Mishina IA, Weleber RG, Yang P, Pennesi ME. Shurygina MF, et al. Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):2. doi: 10.1167/iovs.61.13.2. Invest Ophthalmol Vis Sci. 2020. PMID: 33137195 Free PMC article.
Progression of posterior segment disease was highly variable, with some degree of increased atrophy of the macula or peripheral retina or increased vitreoretinal traction observed in 9 of 12 patients. CONCLUSIONS: Microcephaly due to mutations in KIF11, TUBGCP4, or TUBGCP6 …
Progression of posterior segment disease was highly variable, with some degree of increased atrophy of the macula or peripheral retin …
Treatment of choroidal neovascularization in high myopia.
Montero JA, Ruiz-Moreno JM. Montero JA, et al. Curr Drug Targets. 2010 May;11(5):630-44. doi: 10.2174/138945010791011929. Curr Drug Targets. 2010. PMID: 20196722 Review.
Choroidal neovascularization (CNV) is the most common vision-threatening complication of high myopia. Different therapeutic approaches have been attempted such as thermal laser photocoagulation, surgery and photodynamic therapy with verteporfin (PDT). ...However, th …
Choroidal neovascularization (CNV) is the most common vision-threatening complication of high myopia. Different therapeutic approache …
Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia.
Pakzad-Vaezi K, Mehta H, Mammo Z, Tufail A. Pakzad-Vaezi K, et al. Expert Opin Biol Ther. 2016 Jul;16(7):873-81. doi: 10.1517/14712598.2016.1167868. Epub 2016 Apr 7. Expert Opin Biol Ther. 2016. PMID: 26985834 Review.
It is a significant cause of visual loss in those with pathologic myopia. The current standard of care involves therapy with intravitreal inhibitors of vascular endothelial growth factor (VEGF). ...In the long-term, myopic CNV may be associated with gradual, irrever …
It is a significant cause of visual loss in those with pathologic myopia. The current standard of care involves therapy with i …
Myopic choroidal neovascularization: natural course and treatment.
Ohno-Matsui K, Yoshida T. Ohno-Matsui K, et al. Curr Opin Ophthalmol. 2004 Jun;15(3):197-202. doi: 10.1097/01.icu.0000120709.35941.e9. Curr Opin Ophthalmol. 2004. PMID: 15118506 Review.
RECENT FINDINGS: A recent study evaluating the visual outcome of myopic CNV for at least 10 years after onset in a large series of patients reported that the visual prognosis of myopic CNV without treatment is extremely poor, mainly because of the secondary development of chor …
RECENT FINDINGS: A recent study evaluating the visual outcome of myopic CNV for at least 10 years after onset in a large series of patients …
LONG-TERM TREATMENT OUTCOMES AFTER BEVACIZUMAB THERAPY FOR MACULAR NEOVASCULARIZATION IN WHITE PATIENTS WITH HIGH MYOPIA.
Ravenstijn M, Klaver CCW, Yzer S. Ravenstijn M, et al. Retina. 2023 Mar 1;43(3):444-453. doi: 10.1097/IAE.0000000000003675. Epub 2022 Nov 16. Retina. 2023. PMID: 36395427 Free PMC article.
Of the 27 eyes (23%) who reached 10 years of follow-up, 53% developed MNV-related chorioretinal atrophy. The cumulative incidence of recurrent myopic MNV was 34% at 2 years and 59% at 5 years. Best-corrected visual acuity decrease in eyes with or without recurrent M …
Of the 27 eyes (23%) who reached 10 years of follow-up, 53% developed MNV-related chorioretinal atrophy. The cumulative incide …
Progression of myopic maculopathy after treatment of choroidal neovascularization.
Farinha CL, Baltar AS, Nunes SG, Figueira JP, Pires IA, Cachulo ML, Silva RM. Farinha CL, et al. Ophthalmologica. 2014;231(4):211-20. doi: 10.1159/000357290. Epub 2014 Mar 22. Ophthalmologica. 2014. PMID: 24662778
Eyes were assigned to 4 groups (PDT, IVR, PDT + IVR, dry myopic maculopathy) and evaluated with best-corrected visual acuity, color fundus photography and spectral-domain optical coherence tomography. Chorioretinal atrophy progression was quantified. RESULTS: Fifty- …
Eyes were assigned to 4 groups (PDT, IVR, PDT + IVR, dry myopic maculopathy) and evaluated with best-corrected visual acuity, color fundus p …
Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S, Sencer S, Kebudi R, Tanyıldız B, Cebeci Z, Aydın K. Tuncer S, et al. Acta Ophthalmol. 2016 Nov;94(7):e644-e651. doi: 10.1111/aos.13077. Epub 2016 May 23. Acta Ophthalmol. 2016. PMID: 27214798 Free article.
The main IAC-related periocular complications included transient eyelid oedema (n = 13), ptosis (n = 6) and forehead hyperpigmentation (n = 3), each resolving in 2 weeks to 4 months. Intra-ocular complications included chorioretinal atrophy (n = 9), newly noted reti …
The main IAC-related periocular complications included transient eyelid oedema (n = 13), ptosis (n = 6) and forehead hyperpigmentation (n = …
23 results